1-17 of 17
Agamemnon A. Epenetos
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 2987: Generation of a selectively cytotoxic fusion protein against p53 mutated cancers

Agamemnon A. Epenetos, Christina Kousparou, Aleksandra Filipovic
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 2987.
https://doi.org/10.1158/1538-7445.AM2016-2987
Published: 15 July 2016
View articletitled, Abstract 2987: Generation of a selectively cytotoxic fusion protein against p53 mutated cancers
Journal Articles

Abstract 234: Inhibition of the NOTCH transcription factor complex by a novel hybrid protein leads to effective tumor therapy.

Agamemnon A. Epenetos, Christina Kousparou, Spyros Stylianou, Mahendra Deonarain, Aleksandra Filipovic
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 234.
https://doi.org/10.1158/1538-7445.AM2013-234
Published: 15 April 2013
View articletitled, Abstract 234: Inhibition of the NOTCH transcription factor complex by a novel hybrid protein leads to effective tumor therapy.
Journal Articles

Abstract 4364: TR4 for the treatment of human neoplasms: Novel antiNotch agent

Agamemnon A. Epenetos, Spyros Kyprianou, Silvia Colucci, Christina Kousparou, Mahendra Deonarain
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 4364.
https://doi.org/10.1158/1538-7445.AM2011-4364
Published: 15 April 2011
View articletitled, Abstract 4364: TR4 for the treatment of human neoplasms: Novel antiNotch agent
Journal Articles

Abstract 3332: Engineering functions in cell transduction domains: novel anticancer agents

Agamemnon A. Epenetos, christina kousparou, Spyros Stylianou, mahendra deonarain
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 3332.
https://doi.org/10.1158/1538-7445.AM10-3332
Published: 15 April 2010
View articletitled, Abstract 3332: Engineering functions in cell transduction domains: novel anticancer agents
Journal Articles

Angiolix, a new humanized antibody with function-related anti-breast tumor activity

Jerry A. Peterson, Roberto L. Ceriani, Agamemnon A. Epenetos
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1119–1120.
Published: 01 May 2005
View articletitled, Angiolix, a new humanized antibody with function-related anti-breast tumor activity
Journal Articles

Potent cytotoxicity and inhibition of pan-cell cycle progression by Alchemix, a novel DNA alkylating anthraquinone

Klaus Pors, Paul J. Smith, Agamemnon A. Epenetos, Laurence H. Patterson
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 564–565.
Published: 01 May 2005
View articletitled, Potent cytotoxicity and inhibition of pan-cell cycle progression by Alchemix, a novel DNA alkylating anthraquinone
Journal Articles

Pharmacokinetics, Biodistribution, and Dosimetry of Specific and Control Radiolabeled Monoclonal Antibodies in Patients with Primary Head and Neck Squamous Cell Carcinoma

Anthony Maraveyas, Nick Stafford, Gail Rowlinson-Busza, J. Simon W. Stewart, Agamemnon A. Epenetos
Journal: Cancer Research
Cancer Res (1995) 55 (5): 1060–1069.
Published: 01 March 1995
View articletitled, Pharmacokinetics, Biodistribution, and Dosimetry of Specific and Control Radiolabeled Monoclonal Antibodies in Patients with Primary Head and Neck Squamous Cell Carcinoma
Open the PDF for Pharmacokinetics, Biodistribution, and Dosimetry of Specific and Control Radiolabeled Monoclonal Antibodies in Patients with Primary Head and Neck Squamous Cell Carcinoma in another window
Journal Articles

Radiolabeled Antibody Combined with External Radiotherapy for the Treatment of Head and Neck Cancer: Reconstruction of a Theoretical Phantom of the Larynx for Radiation Dose Calculation to Local Tissues

Anthony Maraveyas, Melvyn Myers, Nick Stafford, Gail Rowlinson-Busza, J. Simon W. Stewart, Agamemnon A. Epenetos
Journal: Cancer Research
Cancer Res (1995) 55 (5): 1020–1027.
Published: 01 March 1995
View articletitled, Radiolabeled Antibody Combined with External Radiotherapy for the Treatment of Head and Neck Cancer: Reconstruction of a Theoretical Phantom of the Larynx for Radiation Dose Calculation to Local Tissues
Open the PDF for Radiolabeled Antibody Combined with External Radiotherapy for the Treatment of Head and Neck Cancer: Reconstruction of a Theoretical Phantom of the Larynx for Radiation Dose Calculation to Local Tissues in another window
Journal Articles

Development of Humoral Immune Responses against a Macrocyclic Chelating Agent (DOTA) in Cancer Patients Receiving Radioimmunoconjugates for Imaging and Therapy

Christos Kosmas, Deborah Snook, Calvin S. Gooden, Nigel S. Courtenay-Luck, Michael J. McCall, Claude F. Meares, Agamemnon A. Epenetos
Journal: Cancer Research
Cancer Res (1992) 52 (4): 904–911.
Published: 01 February 1992
View articletitled, Development of Humoral Immune Responses against a Macrocyclic Chelating Agent (DOTA) in Cancer Patients Receiving Radioimmunoconjugates for Imaging and Therapy
Open the PDF for Development of Humoral Immune Responses against a Macrocyclic Chelating Agent (DOTA) in Cancer Patients Receiving Radioimmunoconjugates for Imaging and Therapy in another window
Journal Articles

Uptake and Distribution of Specific and Control Monoclonal Antibodies in Subcutaneous Xenografts following Intratumor Injection

Gail Rowlinson-Busza, Aristotelis Bamias, Thomas Krausz, Agamemnon A. Epenetos
Journal: Cancer Research
Cancer Res (1991) 51 (12): 3251–3256.
Published: 01 June 1991
View articletitled, Uptake and Distribution of Specific and Control Monoclonal Antibodies in Subcutaneous Xenografts following Intratumor Injection
Open the PDF for Uptake and Distribution of Specific and Control Monoclonal Antibodies in Subcutaneous Xenografts following Intratumor Injection in another window
Journal Articles

Intravesical Administration of Radiolabeled Antitumor Monoclonal Antibody in Bladder Carcinoma

Aristotelis Bamias, Patrick Keane, Thomas Krausz, Gordon Williams, Agamemnon A. Epenetos
Journal: Cancer Research
Cancer Res (1991) 51 (2): 724–728.
Published: 01 January 1991
View articletitled, Intravesical Administration of Radiolabeled Antitumor Monoclonal Antibody in Bladder Carcinoma
Open the PDF for Intravesical Administration of Radiolabeled Antitumor Monoclonal Antibody in Bladder Carcinoma in another window
Journal Articles

Antibody Guided Targeting of Non-Small Cell Lung Cancer Using 111In-labeled HMFG1 F(ab′)2 Fragments

Haralabos P. Kalofonos, Gregory B. Sivolapenko, Nigel S. Courtenay-Luck, Deborah E. Snook, George R. Hooker, Robert Winter, Christopher G. McKenzie, Joyce J. Taylor-Papadimitriou, Peter J. Lavender, Agamemnon A. Epenetos
Journal: Cancer Research
Cancer Res (1988) 48 (7): 1977–1984.
Published: 01 April 1988
View articletitled, Antibody Guided Targeting of Non-Small Cell Lung Cancer Using 111In-labeled HMFG1 F(ab′)2 Fragments
Open the PDF for Antibody Guided Targeting of Non-Small Cell Lung Cancer Using 111In-labeled HMFG1 F(ab′)2 Fragments in another window
Journal Articles

Antibody-guided Localization of Intraperitoneal Tumors following Intraperitoneal or Intravenous Antibody Administration

Gail Rowlinson, Deborah Snook, Albert Busza, Agamemnon A. Epenetos
Journal: Cancer Research
Cancer Res (1987) 47 (24_Part_1): 6528–6531.
Published: 15 December 1987
View articletitled, Antibody-guided Localization of Intraperitoneal Tumors following Intraperitoneal or Intravenous Antibody Administration
Open the PDF for Antibody-guided Localization of Intraperitoneal Tumors following Intraperitoneal or Intravenous Antibody Administration in another window
Journal Articles

Preexisting Human Anti-Murine Immunoglobulin Reactivity Due to Polyclonal Rheumatoid Factors

Nigel S. Courtenay-Luck, Agamemnon A. Epenetos, Christopher G. Winearls, Mary A. Ritter
Journal: Cancer Research
Cancer Res (1987) 47 (16): 4520–4525.
Published: 01 August 1987
View articletitled, Preexisting Human Anti-Murine Immunoglobulin Reactivity Due to Polyclonal Rheumatoid Factors
Open the PDF for Preexisting Human Anti-Murine Immunoglobulin Reactivity Due to Polyclonal Rheumatoid Factors in another window
Journal Articles

Enhancement by γ-Interferon of in Vivo Tumor Radiolocalization by a Monoclonal Antibody against HLA-DR Antigen

Gail Rowlinson, Frances Balkwill, Deborah Snook, George Hooker, Agamemnon A. Epenetos
Journal: Cancer Research
Cancer Res (1986) 46 (12_Part_1): 6413–6417.
Published: 01 December 1986
View articletitled, Enhancement by γ-Interferon of in Vivo Tumor Radiolocalization by a Monoclonal Antibody against HLA-DR Antigen
Open the PDF for Enhancement by γ-Interferon of in Vivo Tumor Radiolocalization by a Monoclonal Antibody against HLA-DR Antigen in another window
Journal Articles

Development of Primary and Secondary Immune Responses to Mouse Monoclonal Antibodies Used in the Diagnosis and Therapy of Malignant Neoplasms

Nigel S. Courtenay-Luck, Agamemnon A. Epenetos, Richard Moore, Mark Larche, Dimitris Pectasides, Babu Dhokia, Mary A. Ritter
Journal: Cancer Research
Cancer Res (1986) 46 (12_Part_1): 6489–6493.
Published: 01 December 1986
View articletitled, Development of Primary and Secondary Immune Responses to Mouse Monoclonal Antibodies Used in the Diagnosis and Therapy of Malignant Neoplasms
Open the PDF for Development of Primary and Secondary Immune Responses to Mouse Monoclonal Antibodies Used in the Diagnosis and Therapy of Malignant Neoplasms in another window
Journal Articles

Limitations of Radiolabeled Monoclonal Antibodies for Localization of Human Neoplasms

Agamemnon A. Epenetos, Deborah Snook, Helga Durbin, Peter M. Johnson, Joyce Taylor-Papadimitriou
Journal: Cancer Research
Cancer Res (1986) 46 (6): 3183–3191.
Published: 01 June 1986
View articletitled, Limitations of Radiolabeled Monoclonal Antibodies for Localization of Human Neoplasms
Open the PDF for Limitations of Radiolabeled Monoclonal Antibodies for Localization of Human Neoplasms in another window